Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells

Summary: Graft-versus-host disease (GVHD) remains a serious limitation of allogeneic hematopoietic cell transplantation (allo-HCT). While post-transplant administration of cyclophosphamide (PTCy) is increasingly used as GVHD prophylaxis, its precise mechanisms of action and its impact on graft-versu...

Descrición completa

Detalles Bibliográficos

Principais autores:	Caroline Ritacco, Murat Cem Köse, Justine Courtois, Lorenzo Canti, Charline Beguin, Sophie Dubois, Benoît Vandenhove, Sophie Servais, Jo Caers, Yves Beguin, Grégory Ehx, Frédéric Baron
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2023-03-01
Series:	iScience
Assuntos:	Medicine Molecular biology Immunology
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2589004223001621
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!